About 75 of breast cancers express estrogen receptor ER О±, and these ER positive breast cancers are typically treated with selective estrogen receptor modulators SERMs such as tamoxifen or aromatase inhibitors such as anastrozole and letrozole in combination with other commonly used chemo or radio ...